Aspire Biopharma Holdings, Inc. (ASBP, ASBPW) (CIK 0001847345) UPLOAD
An UPLOAD letter is the SEC's written comment to the company during a filing review. SEC staff flag accounting issues, ICFR weaknesses, segment-reporting disputes, and revenue-recognition concerns here. Released to EDGAR 20 days after the SEC closes its review.
Key facts
- Accession number
- 0000000000-26-001916
- Form
- UPLOAD
- Filer
- Aspire Biopharma Holdings, Inc. (ASBP, ASBPW) (CIK 0001847345)
- CIK
- 0001847345
- Ticker
- ASBP, ASBPW
- Filed
- 2026-02-24
- SEC file number
- 333-293515
- SIC industry
- 2834
- HQ
- Estero, FL
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1847345/000000000026001916/filename1.pdf
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer